Search

everythinglearnresearchcommunity

for

Search:↓

Proactive monitoring and management are essential to maximize the benefits of Trastuzumab Deruxtecan while minimizing serious side effects.

Chronic scalp pain in trichodynia involves both body-wide and localized increased pain sensitivity.

Hair follicles are hormone-sensitive and involved in growth and other functions, with potential for new treatments, but more research is needed.

Using computers to analyze drugs can find new uses for them, but actual experiments are needed to confirm these uses.

Trastuzumab deruxtecan is effective for HER2-positive breast cancer but requires careful management of side effects.

Substance P may worsen acne by increasing inflammation, but corticosteroids might help by reducing this effect.

A specific immune response helps control mite populations on the skin, maintaining healthy hair follicles.

Pantethine may boost the immune system's ability to fight sarcoma.

Advanced nanocarrier and microneedle drug delivery methods are more effective, safer, and less invasive for treating skin diseases.

Stress may contribute to hair loss in alopecia areata by affecting immune responses and cell death in hair follicles.

The conclusion introduces a new way to classify skin cysts using their shape and genetic markers.

A new peptide, FOL-005, may help treat excessive hair growth by reducing a hair growth promoter, FGF7.

17β-estradiol may help hair growth by increasing cannabinoid receptor type 1.

Higher levels of certain nerve-related proteins are linked to hair loss in women with scalp pain.

Deleting the p63 gene in certain cells causes problems in thymus development and severe hair loss in mice.

Hair ages and thins due to factors like inflammation and stress, and treatments like antioxidants and hormones might improve hair health.

Trichodynia is a painful scalp condition linked to hair loss and inflammation, often with anxiety, affecting more women and needing better treatment options.